R. David Hoover, Director at Elanco Animal Health Inc (ELAN), bought 20,000 shares at $15.18 ($304K) on 2022-09-09, disclosed to the SEC on 2022-09-09.
Open-market purchase of $304k ELAN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ELAN | BUY | 2023-03-15 | $95K | — | Filing → |
| ELAN | BUY | 2023-03-07 | $223K | — | Filing → |
| ELAN | BUY | 2022-05-24 | $467K | — | Filing → |